Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight loss). It is the first medication that targets two hunger hormones at once: GIP and GLP-1. By activating both, it produces stronger weight loss and blood sugar control than older GLP-1-only medications like semaglutide. In the largest clinical trial, people on the highest dose lost an average of 22.5% of their body weight, more than any other FDA-approved weight loss drug.
Expected Weight Loss
In the main weight loss trial, people on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks (about 17 months). At 10 mg, the average was 21.4%. Over a third of people on the highest dose lost 25% or more. For a 200-pound person, 22.5% is roughly 45 pounds.
Cost
Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan).
Frequently Asked Questions
There are 22 clinics prescribing Tirzepatide (Mounjaro and Zepbound) in Phoenix, Arizona listed on GlobalGLP1.com.
Yes, 16 out of 22 Tirzepatide clinics in Phoenix offer telehealth consultations.
Tirzepatide costs in Phoenix vary by clinic and insurance. Without insurance, expect $800-$1,400/month. With insurance, copays range from $25-$200/month. Contact clinics directly for current pricing.
Most GLP-1 clinics in Phoenix do not require a referral. You can schedule a consultation directly. The provider will evaluate your eligibility based on BMI, medical history, and treatment goals.
